Ingo Mellinghoff

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Signal transduction inhibitors and antiangiogenic therapies for malignant glioma
    Ingo K Mellinghoff
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA
    Glia 59:1205-12. 2011
  2. ncbi Will Kinase Inhibitors Make it as Glioblastoma Drugs?
    Ingo K Mellinghoff
    Human Oncology and Pathogenesis Program, Department and Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Curr Top Microbiol Immunol 355:135-69. 2012
  3. ncbi Why do cancer cells become "addicted" to oncogenic epidermal growth factor receptor?
    Ingo Mellinghoff
    Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA
    PLoS Med 4:1620-2. 2007
  4. ncbi Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2
    Marc R J Carlson
    Department of Human Genetics, University of California at Los Angeles and David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, California 90095 1271, USA
    Clin Cancer Res 13:2592-8. 2007

Collaborators

Detail Information

Publications4

  1. ncbi Signal transduction inhibitors and antiangiogenic therapies for malignant glioma
    Ingo K Mellinghoff
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA
    Glia 59:1205-12. 2011
    ..2011 Wiley-Liss, Inc...
  2. ncbi Will Kinase Inhibitors Make it as Glioblastoma Drugs?
    Ingo K Mellinghoff
    Human Oncology and Pathogenesis Program, Department and Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Curr Top Microbiol Immunol 355:135-69. 2012
    ....
  3. ncbi Why do cancer cells become "addicted" to oncogenic epidermal growth factor receptor?
    Ingo Mellinghoff
    Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA
    PLoS Med 4:1620-2. 2007
  4. ncbi Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2
    Marc R J Carlson
    Department of Human Genetics, University of California at Los Angeles and David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, California 90095 1271, USA
    Clin Cancer Res 13:2592-8. 2007
    ..VEGF inhibition reduces edema and tumor burden in some patients with malignant glioma, whereas others show no response. The role of VEGF expression in edema production and the relationship to survival is not well understood...